AU2003262922A1 - Retroductal salivary gland genetic vaccination - Google Patents

Retroductal salivary gland genetic vaccination

Info

Publication number
AU2003262922A1
AU2003262922A1 AU2003262922A AU2003262922A AU2003262922A1 AU 2003262922 A1 AU2003262922 A1 AU 2003262922A1 AU 2003262922 A AU2003262922 A AU 2003262922A AU 2003262922 A AU2003262922 A AU 2003262922A AU 2003262922 A1 AU2003262922 A1 AU 2003262922A1
Authority
AU
Australia
Prior art keywords
retroductal
salivary gland
genetic vaccination
vaccination
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003262922A
Other versions
AU2003262922A8 (en
Inventor
Michael Bennett
Yen-Ju Chen
David Olson
Sean Tucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genteric Inc
Original Assignee
Genteric Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genteric Inc filed Critical Genteric Inc
Publication of AU2003262922A1 publication Critical patent/AU2003262922A1/en
Publication of AU2003262922A8 publication Critical patent/AU2003262922A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU2003262922A 2002-08-30 2003-08-26 Retroductal salivary gland genetic vaccination Abandoned AU2003262922A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US40737502P 2002-08-30 2002-08-30
US60/407,375 2002-08-30
US45399903P 2003-03-11 2003-03-11
US60/453,999 2003-03-11
US63993503A 2003-08-12 2003-08-12
US10/639,935 2003-08-12
PCT/US2003/026872 WO2004020592A2 (en) 2002-08-30 2003-08-26 Retroductal salivary gland genetic vaccination

Publications (2)

Publication Number Publication Date
AU2003262922A1 true AU2003262922A1 (en) 2004-03-19
AU2003262922A8 AU2003262922A8 (en) 2004-03-19

Family

ID=31982347

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003262922A Abandoned AU2003262922A1 (en) 2002-08-30 2003-08-26 Retroductal salivary gland genetic vaccination

Country Status (2)

Country Link
AU (1) AU2003262922A1 (en)
WO (1) WO2004020592A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2477652B1 (en) 2009-09-16 2015-04-15 Vaxart, Inc. Immunization strategy to prevent h1n1 infection
US20170224805A1 (en) 2014-02-20 2017-08-10 Vaxart, Inc. Formulations for small intestinal delivery
JP6912394B2 (en) 2015-06-12 2021-08-04 バクサート インコーポレイテッド Formulations for small intestinal delivery of RSV and norovirus antigens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5885971A (en) * 1995-03-24 1999-03-23 The Regents Of The University Of California Gene therapy by secretory gland expression
US5744460A (en) * 1996-03-07 1998-04-28 Novartis Corporation Combination for treatment of proliferative diseases
US5962429A (en) * 1996-11-22 1999-10-05 University Of Iowa Complexes of adenovirus with cationic molecules
US6372722B1 (en) * 2000-01-19 2002-04-16 Genteric, Inc. Method for nucleic acid transfection of cells

Also Published As

Publication number Publication date
WO2004020592A2 (en) 2004-03-11
AU2003262922A8 (en) 2004-03-19
WO2004020592A3 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
AU2003231176A1 (en) Sequence miner
AU2003231251A1 (en) Ferrule assembly
AU2003243715A1 (en) Thermal interface materials
AUPS323102A0 (en) Removable tile spacer
AU2003225278A1 (en) Secure scan
AU2003258005A1 (en) Deadblow hammer
AU2002322059A1 (en) Improved vaccination against anthrax
AU2003285320A1 (en) Vaccine
AU2003263849A1 (en) Gace spacer
AU2003301316A1 (en) Improved immunotherapy
AU2003272301A1 (en) Carotene-specific lipase
AU2003234955A1 (en) Micromanipulator
AU2003262922A1 (en) Retroductal salivary gland genetic vaccination
AU2003285525A1 (en) Building
AU2002254161A1 (en) M cell directed vaccines
AU2003273035A1 (en) Gene vaccine
AU2003237701A1 (en) Vaccines
AU2003256785A1 (en) Improved shears
AU2003294705A1 (en) NtSM GENE
AU2003297059A1 (en) Chip-in-a-well scanning
EP1595127A3 (en) Chip-in-a-well scanning
AU2003223816A1 (en) Framework construction
AU2003221776A1 (en) Electroporation-mediated transfection of the salivary gland
AU2002347346A1 (en) Dna vaccine
AU2003205657A1 (en) Spacer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase